|
Studies
Conducted with Cetyl Myristoleate
To date there
are several credible patient studies and two double blind,
placebo-controlled studies completed. These are summarized
below.
The first
patient study was conducted by Dr Len Sands of the San Diego
Clinic. He completed a human study on the
effectiveness on Cetyl Myristoleate in 1995. There were 48
arthritis patients in this study. All but two showed significant
improvement in articular mobility (80% or better) and reduction
of pain (70% or better). This study had serious flaws, but was
nevertheless useful as it suggested to many that maybe there was
some hope here and that more scientific studies should
follow.
The first
double blind study followed two years later. Dr. H. Siemandi
conducted a double blind study under the auspices of the Joint
European Hospital Studies Program. There were 431 patients in
the study, 106 who received cetyl myristoleate, 99 who received
cetyl myristoleate and glucosamine, sea cucumber, and hydrolyzed
cartilage; and 226 who received a placebo. Clinical assessment
included radiological test and other studies. Results were 63%
improvement for the cetyl myristoleate group, 87% for the cetyl
myristoleate plus glucosamine group and 15% for the placebo
group.
In August of
2002, a double blind study was published in the Journal or
Rheumatology. The study included sixty-four patients with
chronic knee OA. Half of the patients received a cetyl
myristoleate complex and half a placebo. Evaluations included
physician assessment, knee range of motion with goniometry, and
the Lequesne Algofunctional Index (LAI). The conclusion was that
the CM group saw significant improvement while the placebo group
saw little to none. In fact in their conclusion they state that
CM "may be an alternative to the use of nonsteroidal
anti-inflammatory drugs for the treatment of OA".
Advanced
Medical Systems & Design, Ltd completed a study in Oct 2001.
It was not a double blind study but the study included 1814
arthritis patients. The results showed that over 87% of the
subjects had greater than 50% recovery and over 65% of those
showed from 75% - 100% recovery following a sixteen day regimen.
This is not a scientific study but a study with this may
patients does suggest that there could be a positive benefit to
the use of CM in the treatment of arthritis.
|
